Summary
Introduction
Hosts infected with helminths (e.g. schistosomes) develop various immune responses against invading pathogens, which may also lead to damage to host organs. Consequently, helminths have evolved numerous immune subversive ways to down-regulate host immune defences and limit collateral immunopathology in host organs, allowing the long-term survival of both the hosts and the parasites. [1] [2] [3] Interestingly, epidemiological data and animal experiments indicate that chronic infections with helminths are linked to the decreased prevalence of allergy and autoimmune diseases, including type 1 diabetes, multiple sclerosis, Crohn's disease, rheumatoid arthritis and asthma. 4, 5 Abbreviations: APC, allophycocyanin; BALF, bronchoalveolar lavage fluid; EGFP-Tg, enhanced green fluorescent protein transgenic; FCM, flow cytometry; IL-10, interleukin-10; IL-10R, IL-10 receptor; i.p., intraperitoneally; mTGF-b, membrane-bound TGF-b; OVA, ovalbumin; PE, phycoerythrin; PerCP, peridinin chlorophyll protein; rmIL-10, recombinant murine IL-10; S. japonicum, Schistosoma japonicum; SEA, soluble egg antigens; TGF-b, transforming growth factor-b; Treg, regulatory T 
I M M U N O L O G Y O R I G I N A L A R T I C L E
A heterogeneous population of regulatory T (Treg) cells plays crucial roles in maintaining immune homeostasis and limiting excessive immune responses to infection. To date, multiple Treg cell subsets (e.g. nTreg, pTreg, Tr1, Th3 and CD8 + Treg cells) have been found to exert negative regulation on various immune cells by diverse mechanisms. 6 Many studies have centred on CD4 + CD25 + Foxp3 + Treg cells, which are dominantly induced during schistosome infection and play an important down-regulatory role in limiting protective immunity and immunopathological injury and protecting against immune-mediated diseases. 5, 7, 8 The secretion of high amounts of interleukin-10 (IL-10) is one of the important mechanisms of Treg-mediated suppression. 6 Meanwhile, IL-10 is a pleiotropic cytokine that is highly produced and important in immune regulation during schistosome infection. 9 It is well known that IL-10 mediates its immunosuppressive action on multiple types of cells. 10 It can affect many important functions of monocytes, macrophages and dendritic cells by inhibiting the expression of co-stimulatory molecules, pro-inflammatory cytokines and chemokines. Also, IL-10 can directly inhibit helper T-cell function and proliferation. [10] [11] [12] [13] [14] However, the action of IL-10 on Treg cells themselves is less characterized and seems paradoxical. Previous studies suggest that IL-10 is important for potentiating Treg cell induction and maintaining their suppressive function, [15] [16] [17] whereas the regulation of IL-10 on Treg cells is currently not fully understood.
In this study, by using a murine model with Schistosoma japonica infection we investigated whether and how IL-10 regulates Treg cells. Our results showed that the elevated IL-10 increased Treg cells but impaired their immunosuppressive activity. We further showed that IL-10 increased the levels of serum transforming growth factor-b (TGF-b) but decreased the membrane-bound TGF-b on Treg cells; and finally, IL-10-mediated regulation on Treg cells was also proved in a murine model of asthma. Hence, our data document that IL-10 shows opposite regulation on Treg cells, providing an insight into the mechanism of precise control of immune regulation.
Materials and methods

Ethics statement
All animal experiments were performed in accordance with the Chinese laws for animal protection and experimental guidelines. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Nanjing Medical University for the use of laboratory animals.
Mice, parasites, animal infection and antigen preparation
Specific pathogen-free 7-to 8-week-old female BALB/c mice, wild-type and enhanced green fluorescent protein transgenic (EGFP-Tg) C57BL/6 mice were purchased from SLAC Laboratory (Shanghai, China) and bred in a specific pathogen-free animal facility.
Oncomelania hupensis harbouring S. japonicum (Chinese mainland strain) cercariae were purchased from the Jiangsu Institute of Parasitic Diseases (Wuxi, China). Each mouse was infected percutaneously by exposure of the abdominal skin for 20 min to 12 cercariae of S. japonicum.
Soluble egg antigen (SEA) was prepared as previously described. 18 Protein concentrations were determined using the DC protein assay (Bio-Rad, Hercules, CA).
Cytokine and antibodies
Recombinant murine IL-10 (rmIL-10) was purchased from PeproTech (Rocky Hill, NJ). The rat anti-mouse IL-10 neutralizing antibody (JES5-2A5), rat anti-mouse IL-10 receptor (IL-10R) blocking antibody (1B1.3a) and purified rat IgG1 isotype control antibody were purchased from BioLegend (San Diego, CA). Hamster anti-mouse CD3 antibody (145-2C11) and Alexa Fluor-conjugated anti-Ki-67 were purchased from BD Pharmingen (San Jose, CA). Peridinin chlorophyll protein-conjugated (PerCP-Cy5.5-) anti-CD3, FITC-conjugated anti-CD4, allophycocyanin-conjugated (APC-) anti-CD25, phycoerythrin-conjugated (PE-) Cy7-anti-CD25, PerCP-Cy5.5-anti-Foxp3, PE-anti-Foxp3, PE-Cy7-anti-CD44, PerCPCy5.5-anti-CD62L, PE-anti-CTLA-4, APC-anti-ICOS, PEanti-TGF-b, PE-anti-IL-10R and the Mouse Regulatory T Cell Staining Kit were purchased from eBioscience (San Diego, CA).
Cytokine or antibody administration and ovalbumin sensitization murine models Detailed experimental designs of murine models are shown in the Supplementary material (Fig. S2) .
For rmIL-10 administration, each mouse was injected intraperitoneally (i.p.) with PBS as control or 100 ng of rmIL-10 three times per day (once every 8 hr) for 5 consecutive days. For antibody administration, each mouse was administered i.p. with 500 lg of anti-IL-10, anti-IL-10R or IgG1 isotype control antibodies once a week, beginning 8 weeks after S. japonicum infection and continuing through the following 4 weeks. 19 Briefly, mice were sensitized i.p. with 50 lg of Grade VII chicken ovalbumin (OVA, Sigma-Aldrich, St Louis, MO) adsorbed to 9% potassium alum (Sigma-Aldrich) as previously described, 20 and boosted with the same antigen on days 7, 14 and 21. Mice were then challenged with aerosolized OVA (5 mg/ml) by the intratracheal route for 30 min once daily for 5 consecutive days (days 28-32). All mice were killed 24 hr after final airway challenge to assess airway inflammation.
Bronchoalveolar lavage fluid cell counts
As previously described, 20 after 24 hr of final challenge, mice were terminally anaesthetized, their tracheas were cannulated, and the internal airspaces were lavaged twice with 500 ll PBS. Fluids were centrifuged and pellets were recovered for cell counts. Cytospins were prepared by spinning 5 9 10 5 cells onto poly-L-lysine-coated slides (BDH Laboratory Supplies, Poole, UK) followed by Diff Quick (Boehringer Mannheim, Mannheim, Germany) staining. Differential cell counts were performed on a minimum of 200 cells at a magnification of 100 9.
Histopathology
After 24 hr of final challenge, lungs were excised, fixed in formalin and embedded in paraffin for histopathological analysis. 21 The degree of peribronchial inflammation was evaluated using a semi-quantitative system that takes into account extent and severity of inflammation on a scale from 0 to 4, as previously described. 21 Experiments were performed in a double-blinded fashion.
Cell isolation
Single-cell suspensions were prepared from mouse spleens and used to isolate CD4 + CD25 + and CD4 + CD25 À T cells by using a mouse Treg cell isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany) and a magnetic activated cell sorter (MACS, Miltenyi Biotec) according to the manufacturer's instructions, achieving > 96% purity as determined by flow cytometry (FCM) analysis. Antigen-presenting cells were prepared from single-cell suspensions by negative selection using CD90.2 magnetic microbeads (Miltenyi Biotec) to deplete T cells and were then irradiated with 30 Gy at 2Á7 Gy/min using a 137 Cs source (Gammacell 1000 Elite; Nordion International Inc., Kanata, Ontario, Canada).
In vitro treatment of cells
Spleen cells or purified CD4
+ CD25 + Treg cells from S. japonicum-infected mice were pre-treated with 20 lg/ ml of anti-IL-10, anti-IL-10R, isotype IgG1 antibodies or medium alone for 30 min in complete PRMI-1640 (containing 10% fetal calf serum, 100 U/ml of penicillin plus 100 lg/ml streptomycin) in a 24-well plate. Subsequently, SEA (20 lg/ml), anti-CD3 (2 lg/ml) or rmIL-10 (20 ng/ ml) were added to the cultures. After 72 hr, cells were collected for FCM analysis and/or supernatants were collected for cytokine detection by ELISA.
Suppression assay
Antigen-presenting cells ( 
Flow cytometry analysis
To analyse CD4 + CD25 + Foxp3 + Treg cells and their surface effector phenotype, the Mouse Regulatory T Cell Staining Kit (eBioscience) was used according to the manufacturer's recommendations. In brief, 1 9 10 6 spleen cells or cells collected from co-cultures were stained with anti-CD3-PerCP-Cy5. Following immunofluorescence staining, cells were examined by FCM using a FACS Calibur or Verse instrument (BD Bioscience) and analysed using CELLQUEST (BD Bioscience) or FLOWJO (Tree Star, Ashland, OR; version 10.0.7).
Adoptive transfer
Freshly isolated CD4 + CD25 + Treg cells (5 9 10 5 cells per mouse) from S. japonicum-infected mice (8 weeks post-infection) were adoptively transferred intravenously into OVA-sensitized mice as indicated in the Supplementary material (Fig. S2c) . 22 The recipient OVA-sensitized mice were immediately injected i.p. with rmIL-10 or PBS starting on day 28 after the first OVA sensitization, then subjected to OVA challenge. All mice were killed 24 hr after the final airway challenge.
Detection of cytokines
ELISA kits (Bender MedSystems, Vienna, Austria) were used for measurements of IL-10 and TGF-b, according to the manufacturer's instructions.
Statistical analysis
The statistical analysis was performed using SPSS version 10.1 for Windows (SPSS, Inc., Chicago, IL). The Kolmogorov-Smirnov test was used to evaluate the normality of the distribution of the examined quantitative variables. Where normality tests were passed, a Student's t-test was used for analysing the differences between two groups. Otherwise, a Mann-Whitney's U-test was used. The differences between more than two groups were analysed with one-way analysis of variance with a least squares difference post hoc test. P < 0Á05 was considered statistically significant.
Results
Schistosoma japonicum infection increased serum IL-10 levels and Treg cell frequency but decreased immunosuppressive activity of Treg cells in mice Results in Fig. 1(a-c) showed that both the serum levels of IL-10 and the frequency of CD4 + CD25 + Foxp3 + Treg cells were significantly increased in S. japonicuminfected mice compared with normal mice. However, the S. japonicum infection did not change the expression levels of Foxp3 by Treg cells (Fig. 1d,e) . Intriguingly, by a classical [ 3 H]thymidine incorporation assay, the immunosuppressive activity of CD4 + CD25 + Treg cells from S. japonicum-infected mice was shown to be significantly impaired compared with those derived from normal mice (Fig. 1f) . Similar results were obtained by the Ki-67-based assay (Fig. 1g,h ). These results illustrate that schistosome infection elevates the Treg cell frequency and serum IL-10 level but decreases the immunosuppressive activity of Treg cells.
IL-10 administration increased Treg cells but decreased their immunosuppressive activity in S. japonicum-infected mice
To demonstrate the possible effect of IL-10 on Treg cells during schistosome infection, we first detected IL-10R expression on CD4 + CD25 + Treg cells. As shown in the Supplementary material (Fig. S1 ), we observed a doubled frequency of IL-10R + CD4 + CD25 + Treg cells in S. japonicum-infected mice compared with that in normal mice. The S. japonicum-infected mice were next injected i.p. with rmIL-10 to further increase IL-10 levels in vivo (see Supplementary material, Fig. S2a ). Twenty-four hours after the last injection, the frequency of CD4 + CD25 + Foxp3 + Treg cells in the spleen was determined by FCM. Results showed that when compared with untreated or PBS-injected control mice, rmIL-10 administration resulted in a greater increase of Treg cells (Fig. 2a,b ) in S. japonicum-infected mice, but did not increase the levels of Foxp3 in these Treg cells (Fig. 2c,  d ). In addition, both [ 3 H]thymidine incorporation and Ki-67-based assays showed that rmIL-10 injection of S. japonicum-infected mice resulted in a significant impairment of the immunosuppressive activity of Treg cells compared with PBS or blank controls ( Fig. 2e-g ). These findings demonstrate that a higher level of IL-10 contributes to an increased frequency but decreased immunosuppressive activity of Treg cells during S. japonicum infection.
In vitro IL-10 treatment enhanced Treg cell induction by SEA but impaired their immunosuppressive activity Previous reports, including our own, showed that SEAs are responsible for Treg cell induction in vitro and in vivo.
23,24 Therefore, we further investigated the effect of IL-10 on Treg cells in an in vitro SEA induction system. The SEA in vitro stimulation alone induced significantly higher frequencies of Treg cells in spleen cells from S. japonicum-infected mice compared with untreated control mice (Fig. 3a,b ). The addition of rmIL-10 in vitro further increased the frequency of SEAinduced Treg cells (Fig. 3a,b) . Subsequently, suppression assays were performed to further examine the in vitro effect of rmIL-10 on the immunosuppressive activity of Treg cells. As shown in Fig. 3 (c-e), the in vitro treatment with rmIL-10 resulted in significant impairment of suppressive activity of Treg cells. Hence, these in vitro data further indicate that IL-10 contributes to increase the frequency but decrease the immunosuppressive activity of Treg cells.
Injection of anti-IL-10 or anti-IL-10R antibody decreased the frequencies but enhanced immunosuppressive activity of Treg cells in S. japonicum-infected mice
The activity of IL-10 is mediated by binding of its specific cell surface receptor IL-10R. 10 Therefore, we blocked IL-10 signalling by i. assay has been performed three times on independent cell samples. FCM dot plots or histograms are representative of three independent experiments. Data (means AE SD) are representative of three independent experiments. *P < 0Á05, **P < 0Á01, ***P < 0Á001, n.s., not significant. (Fig 5a,b) . In addition, the in vitro suppression assays showed that treatment with either anti-IL-10 or anti-IL-10R antibody restored the immunosuppressive activity of Treg cells ( Fig. 5c-e) . Taken together, these in vitro results further indicate the regulatory role of IL-10 on Treg frequencies and suppressive activity.
IL-10 administration attenuated Treg-mediated suppression of asthma airway inflammation
To further confirm the above findings, the OVA-sensitized asthma murine model was adopted and the Supplementary material (Fig. S2c) shows the experimental designs. Treg cells were purified from S. japonicuminfected mice and adoptively transferred into mice with asthma. Meanwhile the recipient mice were injected immediately with rmIL-10 or PBS as control. As shown in Fig. 6 , either adoptively transferring of Treg cells alone or rmIL-10 injection alone in mice with asthma significantly limited the lung pathology (Fig. 6a) , decreased average histological scores (Fig. 6b) , and infiltrating inflammatory cells in the airways (Fig. 6c) . However, injection of rmIL-10 in mice with asthma and transferred Treg cells impaired Treg-mediated immunosuppression of airway immunopathology (Fig. 6a,b ) and inflammatory cell infiltration (Fig. 6c) . Taken together, these in vivo data suggest that the rmIL-10 attenuated the immunosuppression on airway inflammation in Treg-transferred mice with asthma. (Fig. 7a) .
Membrane-bound TGF-b (mTGF-b) based cell-cell contact has been considered one of the primary mechanisms of suppression by Treg cells. 27, 28 Our result showed that S. japonicum infection decreased both the frequencies of mTGF-b-expressing Treg cells and their surface expression levels of mTGF-b (Fig. 7b-d) . Injection of rmIL-10 in S. japonicum-infected mice further reduced both the frequencies of mTGF-b-expressing Treg cells and their surface expression levels of mTGF-b (Fig. 7b-d) .
In addition, we also analyse the activation Therefore, these results imply that IL-10-mediated regulation of the levels of soluble TGF-b and mTGF-b on Treg cells may be responsible for the increase of the frequency but impairment of the immunosuppressive activity of Treg cells in S. japonicum-infected mice, although the mechanisms are currently unknown and need further extensive investigation in future.
IL-10 in vitro treatment regulated mTGF-b expression on surface of Treg cells
To further confirm the regulatory effects of IL-10 on mTGF-b expression on Treg cells in vitro, spleen cells from S. japonicum-infected mice were cultured with SEA in the presence or absence of rmIL-10 and then analysed by FCM. Consistent with in vivo data above, SEA in vitro treatment decreased both the frequencies of mTGF-bexpressing Treg cells and their surface expression levels of mTGF-b (Fig. 8a-c) . In addition, rmIL-10 in vitro treatment further significantly reduced the frequencies of TGF-b-expressing Treg cells as well as their TGF-b expression levels (Fig. 8a-c) . Therefore, these in vitro results indicate that IL-10 regulates the expression of surface mTGF-b on Treg cells.
To further investigate the possible direct regulation of IL-10 on Treg cells, CD4 + CD25 + Treg cells were purified from normal or S. japonicum-infected mice and treated with IL-10 and in vitro stimulation with or without SEA. As shown in Fig. 8(d-f) , S. japonicum infection decreased both frequencies of mTGF-b-expressing Treg cells and their surface expression levels of mTGF-b (Fig. 8d-f) . SEA in vitro treatment further reduced both the frequencies of TGF-b-expressing Treg cells and their mTGF-b expression levels (Fig. 8d-f) . Furthermore, IL-10 treatment of Treg cells further enhanced SEA-mediated reduction of the frequencies of mTGF-b-expressing Treg cells and their mTGF-b expression levels (Fig. 8d-f ).
Discussion
Precisely controlled immune regulation is important in hosts with chronic infections, including schistosomiasis.
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Iso Ab Anti-IL-10  Anti-IL-10R  4·46  4·56  2·99  13·91  8·59 4·02  9·08  13·82   5·29  5·34  5·19  5·11  Foxp3   CD25  (CD3  + CD4 Such balanced immune regulation is necessary both for the invading pathogens to escape or attenuate the host immune responses and for the hosts to minimize pathology. 3, 29 Studies have highlighted the critical roles of Treg cells and IL-10 in regulating immune responses, for example, both of which are highly induced and essential regulators for controlling the immune response during chronic schistosome infections. 9, [30] [31] [32] [33] However, the regulatory links between these two critical regulators have remained unclear. Here, our results proved that IL-10 mediated opposite regulation on Treg cells by using murine models of schistosomiasis japinica and asthma.
Consistent with previous reports, our results showed that the frequencies of Treg cells and the serum levels of IL-10 increased in parallel in mice after S. japonicum infection. 9, [33] [34] [35] [36] Previous studies have suggested that IL-10 may contribute to Treg cell induction; 37 however, in this study there was a surprising result that the immunosuppressive activities of Treg cells from mice with S. japonicum infection were significantly lower compared with those from uninfected mice. It is well established that IL-10, an important negative regulator, inhibits the activities of multiple cell types, including helper T cells, dendritic cells, macrophagesand natural killer cells. 10, 38, 39 The function of IL-10 is mediated through activation of IL-10R on target cells. 10 A previous study has observed higher expression of IL-10R on CD4 + Foxp3 + Treg cells than on CD4 + Foxp3 À conventional T cells. 40 In our study, we further observed that S. japonicum infection doubled the expression of IL-10R on CD4 + Foxp3 + Treg cells. Therefore, it is likely that IL-10 may provide a negative regulatory loop and conversely suppress the immunosuppressive activity of Treg cells.
In this study, by using S. japonicum-infected or OVAsensitized asthma murine models, both our in vivo and in vitro data proved that IL-10 has opposite regulation on Treg cells, increasing the frequencies while reducing the immunosuppressive activities of Treg cells. This finding provides the evidence to suggest that Treg cells, as essential regulators of the immune system, can be positively and negatively regulated simultaneously by another critical regulator of IL-10. In another words, the regulatory effects of IL-10 on immune responses can be bidirectional. Our results indicate that at least partially mediated by IL-10, the quantity and immunoregulatory activity of Studies suggest that IL-10 plays a key role in maintaining Foxp3 expression in Treg cells, which is the most crucial transcription factor for conferring their development and suppressive function. 17, [41] [42] [43] We show here, however, that the further increase of mouse serum IL-10 by rmIL-10 injection in S. japonicum-infected mice did not further increase Foxp3 expression in Treg cells. One possibility is that the basal levels of IL-10 in mice may already be sufficient to maintain Foxp3 expression. Our result showed that in parallel with impaired Treg cell suppressive activity, IL-10 treatment also led to the reduction of mTGF-b expression on Treg cells, which is thought to be an important mechanism of Treg-mediated cell-cell contact immunosuppression. 27, 28 Hence, this might suggest a mechanism for IL-10-mediated regulation on Treg cell function, but this requires more experiments for further clarification. In addition, due to functional plasticity, 44 Treg cells may adapt to environmental elevated IL-10 and consequently manifest functional deterioration by reprogramming into an effector-like phenotype. However, in addition to mTGF-b, our study still cannot rule out the possibility that there are other unknown factors that may relate to regulation of Treg cells by IL-10 during S. japonicum infection, which needs intensive study in the future.
Studies have shown that CD4 + CD25 + Treg cells can be induced by helminth infection to down-regulate the host's immune response. 5, 7, 8 Binding of soluble TGF-b to its receptor was proved to play an essential role in conversion of naive peripheral CD + CD25 À T cells into Foxp3 + Treg cells. 25 Here, we showed that IL-10 contributed to the increase of serum TGF-b in S. japonicum-infected mice. These results suggest that IL-10 may contribute to the increase of Treg cells during S. japonicum infection by up-regulating serum TGF-b level. In addition, we observed that the proportion of aTreg within total Treg cells decreased while that of rTreg cells increased in IL-10-injected mice. Given that aTreg cells are more prone to apoptosis and that rTreg cells are highly proliferative upon stimulation, 45 it is possible that the IL-10-induced rTreg/aTreg ratio change could be involved in the increase of Treg cells during S. japonicum infection. However, whether and how this change in rTreg/aTreg ratio affects the overall immunosuppressive function of Treg cells is not yet clear. Although our current findings may help to explain the contradictory results that IL-10 increases Treg cells while impairing their immunosuppressive activities, further evidence and detailed mechanisms for these findings require future study.
In conclusion, our study present evidence in S. japonicum-infected and OVA-sensitized asthma mouse models that IL-10 has bidirectional regulatory roles in Treg cells, increasing Treg cells while impairing their immunosuppressive activities. Our findings provide new insight into the mechanisms involved in regulating the homeostasis of Treg cells to prevent overwhelming immunosuppression and suggest a potential intervention target for treatment of chronic infection, cancer, allergy, autoimmune disease and transplantation. 
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